Shivalik Rasayan Ltd

Shivalik Rasayan Ltd

₹ 550 -0.54%
05 Jun - close price
About

Incorporated in 1979, Shivalik Rasayan Ltd is a manufacturer of Agrochemicals & Active Pharma Ingredients[1]

Key Points

Business Overview:[1]
SRL is the largest Indian producer of Dimethoate Technical and second largest Indian producer of Malathion Technical. It also manufactures organophosphorus-based insecticides and chemicals. Apart from this, company does development of Oncology and Non-Oncology active pharmaceutical ingredients and their finished dosage forms

  • Market Cap 855 Cr.
  • Current Price 550
  • High / Low 879 / 500
  • Stock P/E 61.6
  • Book Value 256
  • Dividend Yield 0.09 %
  • ROCE 4.44 %
  • ROE 3.59 %
  • Face Value 5.00

Pros

  • Company is expected to give good quarter
  • Debtor days have improved from 88.5 to 66.6 days.

Cons

  • Promoter holding has decreased over last quarter: -0.58%
  • Tax rate seems low
  • Company has a low return on equity of 3.76% over last 3 years.
  • Dividend payout has been low at 6.49% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
25.39 24.74 22.80 21.78 24.26 22.52 23.51 23.73 23.92 31.58 37.70 40.16 39.78
20.07 18.57 17.65 17.67 20.63 18.10 18.49 19.76 20.39 25.65 31.25 33.55 32.41
Operating Profit 5.32 6.17 5.15 4.11 3.63 4.42 5.02 3.97 3.53 5.93 6.45 6.61 7.37
OPM % 20.95% 24.94% 22.59% 18.87% 14.96% 19.63% 21.35% 16.73% 14.76% 18.78% 17.11% 16.46% 18.53%
1.52 0.49 0.33 0.83 0.55 0.04 0.01 0.67 0.93 0.05 0.06 1.46 0.48
Interest 0.32 0.26 0.26 0.39 0.50 0.52 1.06 0.93 0.72 1.21 1.41 1.50 2.06
Depreciation 1.32 1.48 1.22 1.35 1.19 1.12 1.62 1.21 1.34 1.72 2.05 2.63 2.30
Profit before tax 5.20 4.92 4.00 3.20 2.49 2.82 2.35 2.50 2.40 3.05 3.05 3.94 3.49
Tax % -4.04% 1.02% -1.00% 9.69% -32.53% 10.28% 50.21% 7.60% -6.67% -0.66% -13.11% -1.78% 4.58%
5.40 4.87 4.04 2.89 3.31 2.53 1.17 2.31 2.56 3.07 3.46 4.02 3.33
EPS in Rs 3.73 3.36 2.79 1.99 2.28 1.70 0.75 1.48 1.65 1.97 2.22 2.58 2.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
35 41 43 41 44 48 61 85 99 94 94 149
33 38 38 34 36 42 51 66 76 74 77 123
Operating Profit 2 3 5 7 7 6 9 19 23 19 17 26
OPM % 6% 7% 11% 17% 17% 13% 16% 22% 23% 20% 18% 18%
0 0 1 1 1 4 1 0 2 2 2 2
Interest 0 0 1 2 1 1 1 1 1 1 3 6
Depreciation 0 0 0 0 0 1 1 6 5 5 5 9
Profit before tax 2 3 4 5 6 9 9 13 19 15 10 14
Tax % 34% 33% 33% 33% 19% -3% -0% -1% -3% -3% 15% -3%
1 2 3 3 5 9 9 13 19 15 9 14
EPS in Rs 1.37 2.10 3.10 3.84 4.84 6.47 6.35 9.20 13.36 10.42 5.55 8.91
Dividend Payout % 0% 0% 0% 10% 8% 8% 4% 5% 4% 5% 9% 6%
Compounded Sales Growth
10 Years: 14%
5 Years: 20%
3 Years: 15%
TTM: 59%
Compounded Profit Growth
10 Years: 23%
5 Years: 10%
3 Years: -11%
TTM: 61%
Stock Price CAGR
10 Years: %
5 Years: 17%
3 Years: -12%
1 Year: -3%
Return on Equity
10 Years: 6%
5 Years: 5%
3 Years: 4%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 3 4 7 7 7 7 7 8 8
Reserves 6 8 10 14 42 153 161 173 266 284 366 390
0 0 11 14 8 9 0 11 15 40 55 61
9 11 12 7 7 10 18 31 29 34 42 53
Total Liabilities 18 23 37 38 61 178 186 223 318 365 471 512
6 7 8 8 15 16 18 120 128 126 122 250
CWIP 0 0 0 0 0 11 61 0 3 57 117 0
Investments 0 0 16 18 27 27 39 53 55 65 73 74
12 16 13 12 19 124 68 49 131 117 159 188
Total Assets 18 23 37 38 61 178 186 223 318 365 471 512

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1 4 6 4 -2 -12 -7 46 7 -13 -1 -1
0 -0 -17 -2 -16 -9 -65 -61 -16 -65 -69 -20
0 1 7 -2 19 104 -9 10 76 21 83 22
Net Cash Flow -0 4 -4 1 2 83 -81 -5 66 -57 13 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 93 80 61 47 64 66 49 70 25 76 123 67
Inventory Days 8 5 14 22 36 82 33 45 97 256 328 268
Days Payable 103 126 139 76 66 92 166 119 108 154 102 114
Cash Conversion Cycle -2 -41 -64 -8 34 56 -83 -4 14 178 348 220
Working Capital Days 17 -11 -40 -37 38 169 202 33 97 212 251 187
ROCE % 23% 29% 28% 25% 18% 9% 6% 7% 8% 5% 4% 4%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
50.32% 50.32% 50.32% 50.32% 50.05% 47.95% 47.95% 47.95% 47.95% 47.95% 47.95% 47.37%
0.04% 0.01% 0.01% 0.01% 0.35% 0.66% 1.18% 2.99% 2.15% 3.28% 4.33% 4.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.24% 0.59% 0.88% 0.88% 0.88% 0.88% 0.64%
49.64% 49.67% 49.67% 49.67% 49.60% 51.14% 50.28% 48.17% 49.00% 47.87% 46.81% 47.72%
No. of Shareholders 7,7268,3808,5798,4608,5569,1909,1499,39810,00110,62711,63312,841

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls